课题基金 / 基金详情

Program in Molecular and Cellular Biosciences

Program in Molecular and Cellular Biosciences
分子和细胞生物科学项目
批准号:
7084503
负责人:
Gary Thomas
金额:
$16.65万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2010-06-30

项目摘要

项目成果

Gary Thomas的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本申请申请资助俄勒冈健康与科学大学分子与细胞生物科学(PMCB)专业博士前研究生的培训。这个跨学科项目汇集了来自五个基础科学系(生物化学和分子生物学、细胞和发育生物学、分子和医学遗传学、分子微生物学和免疫学、生理学和药理学)及其附属研究机构的175名教职员工,为一年级和二年级的研究生提供成为成功的研究科学家所需的理论和实验室基础。这项提议将支持目前在PMCB注册的119名博士生中的6名,用于他们头两年的培训。这项应用中的80名培训教员因其在生物物理、分子、细胞和开发方法方面的专业知识而在国际上得到认可,这些方法使用最先进的方法解决重要和引人注目的生物学问题。值得注意的是,研究生还直接参与了开创性的翻译研究,从开发第一个癌症小分子抑制剂(Gleevec)到第一个肝脏干细胞疗法,肥胖的分子基础,以及针对新出现的病原体的新疫苗的开发。我们的计划为符合条件的学生在第一年提供共同的、严格的教学基础,并在第二年学生开始专门化时继续基础。学生还参加系列研讨会、项目务虚会、教学,并可能参加科学会议。学生必须在第一年结束时成功通过综合笔试,并在第二年结束时通过资格考试,在这一考试中,他们准备并为原创研究方案辩护。随后,学生被正式录取到五个参与系中的一个,进行一项研究项目,以获得哲学博士学位。重要的是,OHSU充满活力的研究社区,再加上基础和临床研究设施的临近,为博士生在培训期间形成跨学科合作提供了独特的机会,并获得了他们所从事的与健康相关的基础科学研究的欣赏。
英文摘要
DESCRIPTION (provided by applicant): This application requests funds to support the training of predoctoral students in the Program in Molecular and Cellular Biosciences (PMCB) at Oregon Health & Science University. This interdisciplinary program brings together 175 faculty members from five basic science departments (Biochemistry and Molecular Biology, Cell and Developmental Biology, Molecular and Medical Genetics, Molecular Microbiology and Immunology, and Physiology and Pharmacology) and affiliated research institutes to provide first- and second-year graduate students with the theoretical and laboratory foundation they require to become successful research scientists. This proposal will support six Ph.D. students out of the 119 currently enrolled in the PMCB for their first two years of training. The 80-member training faculty members in this application are internationally recognized for their expertise in biophysical, molecular, cellular, and developmental approaches to important and compelling biological questions using state-of-the art methodologies. Notably, graduate students also directly participate in ground-breaking translational research, ranging from the development of the first small molecule inhibitor of cancer (Gleevec) to the first liver stem cell therapy, the molecular basis of obesity, and the development of new vaccines for emerging pathogens. Our program offers qualified students a common, rigorous didactic grounding for the first year, and continued grounding as students begin to specialize during their second year. Students also participate in seminar series, program retreats, teaching, and may attend scientific meetings. Students must successfully pass a comprehensive written exam at the end of their first year and a qualifying exam at the end of their second year, in which they prepare and defend an original research proposal. Subsequently, students are formally admitted to one of the five participating departments to conduct a research project leading to the awarding of a Doctorate of Philosophy. Importantly, the dynamic research community at OHSU, combined with the proximity of basic and clinical research facilities, provide a unique opportunity for Ph.D. students to form cross-discipline collaborations during their training and to gain an appreciation of the health-relatedness of the basic science research that they undertake.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of PPAR alpha by PACS-2 in response to nutrient stress
Regulation of TRAIL Induced Apoptosis in Cancer Cells
Regulation of TRAIL Induced Apoptosis in Cancer Cells
Regulation of TRAIL Induced Apoptosis in Cancer Cells
国内基金
海外基金
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
  • 批准号:
    81300605
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    唐琳
  • 依托单位:
Molecular Plant
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
Molecular Plant